Guggenheim says investors should own this biotech stock
Analysts at Guggenheim expressed optimism about the outlook of one biotech stock after it announced highly positive top-line results for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

